Proteomics awarded vital CE Mark registration for PromarkerD
Apr 16, 2020
Next Investors
Apr 16, 2020 |
3 min
Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics, has secured CE Mark registration for its PromarkerD Immunoassay kit as an IVD medical device (in vitro diagnostic).
